On Wednesday, Shares of Trimble Navigation Limited (NASDAQ:TRMB), gained 0.49% to $ 16.42.
Trimble, introduced a rugged, handheld computer with an integrated Ultra-High Frequency (UHF) RFID capability designed to read both the rail-industry specific Automatic Equipment Identification (AEI) tags and the Electronic Product Code (EPC) tags used worldwide—the Trimble® Juno® T41 R-AEI.
“Trimble’s fundamental focus for the rail industry is to provide solutions that drive agility, improve efficiency and provide better visibility into operations to maximize productivity,” said Jim Sheldon, general manager of Trimble’s Mobile Computer Solutions Division. “With the introduction of the Juno T41 R-AEI, we are now expanding our broad range of solutions to comprise a powerful field computer that can provide flexibility, connectivity and real-time business intelligence to the rail industry RFID tracking and asset administration.”
Trimble Navigation Limited provides technology solutions to enhance the work processes of office and mobile field professionals worldwide. The company’s Engineering and Construction segment offers field and office software for route selection and design; systems to guide and control construction equipment; systems to monitor, track, and manage assets, equipment, and workers; software to share and communicate data; 3D conceptual design and modeling software; BIM software for design, construction, and maintenance; integrated site layout and measurement systems; application products; integrated workplace administration services software; capital program and facility administration solutions; and field based data collection systems and software, communications systems, and back-office software.
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), inclined 7.95% to $13.99, during its last trading session.
Amicus Therapeutics, has successfully accomplished its formerly declared acquisition of 100% of the capital stock of Scioderm, Inc. a privately-held biopharmaceutical company focused on developing innovative therapies for treating diseases with high unmet need.
“The successful closing of the Scioderm acquisition is another important step forward toward fulfilling our patient-centric vision to build one of the world’s leading rare disease biotechnology companies,” said John F. Crowley, Chairman and Chief Executive Officer of Amicus. “We now have one of the industry’s leading pipelines of advanced therapies for devastating rare and orphan diseases. Within the next 12 months, we have the potential to have a marketed product for Fabry disease in the EU, marketing applications ready to submit for our investigational product for Epidermolysis Bullosa (EB) in the US and EU, and a Pompe program entering Phase 3 development. Recently we believe that Amicus is stronger than ever and has the potential to create noteworthynear- and long-term value for patients in addition to our shareholders.”
Amicus Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutic products for rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease.
At the end of Wednesday’s trade, Shares of Vishay Intertechnology (NYSE:VSH), gained 3.30% to $9.69.
Vishay Intertechnology, expanded its IHLD series of low-profile, high-current dual inductors with a new device in the 3232 case size. Offering a high operating temperature range to +155 °C, the automotive-grade IHLD-3232HB-5A saves board space by combining two inductors in one 9.75 mm by 9.14 mm package.
The Vishay Dale inductor released recently is optimized for automotive and commercial class D amplifier circuits, where the device reduces board space requirements and offers improved performance over multiple individual inductors. In addition, the IHLD-3232HB-5A is designed for excellent inductance stability over temperature and DC current, providing high-quality sound and low harmonic distortion due to linear saturation performance. The inductor pair is designed with very low coupling for minimal crosstalk between inductors.
Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive components in the United States, Europe, and Asia. The company operates in five segments: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors, and Capacitors.
Finally, Diamond Resorts International Inc (NYSE:DRII), ended its last trade with 1.39% gain, and closed at $23.39.
Little Passports, declared a contract with Diamond Resorts International, a global leader in the hospitality and vacation ownership industries. Customized Little Passports World Edition subscriptions are now available for purchase exclusively to members of THE Club at Diamond Resorts International® who are enrolled in the World Discovery Kids Club.
“A relationship with Diamond Resorts was a natural partnership for us,” said Amy Norman, co-founder and co-CEO, Little Passports. “They are a leading, global hospitality company, and we are thrilled to support their youngest members with customized, educational and fun content that will further enhance their Diamond Resorts experience.”
Diamond Resorts International, Inc. operates in the hospitality and vacation ownership industry in the United States, Hawaii, Canada, Mexico, the Caribbean, Central America, South America, Europe, Asia, Australia, New Zealand, and Africa.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
